Increased plasma levels of galectin-1 in pancreatic cancer: potential use as biomarker

Pancreatic ductal adenocarcinoma (PDA) is the most frequent type of pancreatic cancer and one of the deadliest diseases overall. New biomarkers are urgently needed to allow early diagnosis, one of the only factors that currently improves prognosis. Here we analyzed whether the detection of circulati...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Martinez-Bosch, Neus, Barranco, Luis E., Orozco, Carlos A., Moreno, Mireia, Visa, Laura, Iglesias, Mar, Oldfield, Lucy, Neoptolemos, John P., Greenhalf, William, Earl, Julie, Carrato, Alfredo, Costello, Eithne, Navarro, Pilar
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2018
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6152472/
https://ncbi.nlm.nih.gov/pubmed/30250644
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.26034
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars